Nicotine-Containing Electronic Cigarette for Tobacco Addiction
This trial is testing whether smokers who switch to an electronic cigarette with or without nicotine will have better health outcomes than smokers who continue to smoke regular cigarettes.
- Tobacco Addiction
Inclusion CriteriaYou will be eligible if you check “Yes” for the criteria below
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Find a site
Who is running the clinical trial?
Frequently Asked Questions
Are there any openings currently available for volunteers to join this experiment?
"Affirmative. The information available on clinicaltrials.gov reflects the fact that this medical study, initially posted for recruitment on April 22nd 2022, is presently recruiting. About 240 participants must be sourced from a single location."
How can I become part of this research initiative?
"This clinical trial is recruiting 240 applicants aged between 21 and 70 who are dependent on tobacco. Additionally, they must have smoked ≥5 cigarettes daily for the last 12 months, utilise regular filtered or machine-rolled cigarettes with a filter, exhale CO measurement of at least 6 ppm during their initial visit, not attempted to quit smoking in the past month, be willing to completely switch over to an e-cig as part of this study and attend regular visits over 7 weeks; furthermore they ought to possess literacy in English and understanding/consent towards all procedures related to the investigation."
How many individuals have registered for participation in the research project?
"That is correct. This clinical trial's data, which was initially posted on April 22nd 2022 and recently updated, can be found on the website of clinicaltrials.gov where it has been confirmed that this medical experiment is actively recruiting candidates with a total requirement for 240 patients from one location."
Could you elucidate whether individuals of sub-20 years are eligible for this research trial?
"According to the guidelines of this study, only individuals between 21 and 70 years old can be enrolled."